Agios Pharmaceuticals, Inc. (AGIO) stock analysis
AGIO · Agios Pharmaceuticals, Inc.
Latest recorded price: USD 30.15
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 56.0%, free cash flow margin -698.3%, ROIC -130.4%. The model flags 2 risk signals for this company (1 high severity).
Similar companies in Healthcare
- Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY)
- AnaptysBio, Inc. - Common Stock (ANAB)
- Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR)
- Aurinia Pharmaceuticals Inc - Common Shares (AUPH)
- Axsome Therapeutics, Inc. - Common Stock (AXSM)
- BridgeBio Pharma, Inc. - Common Stock (BBIO)
- Beam Therapeutics Inc. - Common Stock (BEAM)
- BioMarin Pharmaceutical Inc. - Common Stock (BMRN)